CN102552492B - 一种治疗带状疱疹的中药组合物及其制备方法 - Google Patents
一种治疗带状疱疹的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102552492B CN102552492B CN201210023151.XA CN201210023151A CN102552492B CN 102552492 B CN102552492 B CN 102552492B CN 201210023151 A CN201210023151 A CN 201210023151A CN 102552492 B CN102552492 B CN 102552492B
- Authority
- CN
- China
- Prior art keywords
- parts
- herpes zoster
- chinese medicine
- scutellaria
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title description 12
- 239000003814 drug Substances 0.000 claims abstract description 51
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 21
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 241000722953 Akebia Species 0.000 claims abstract description 18
- 241000931705 Cicada Species 0.000 claims abstract description 18
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 18
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 18
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 18
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 18
- 229940010454 licorice Drugs 0.000 claims abstract description 18
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 16
- 235000000228 Citrus myrtifolia Nutrition 0.000 claims abstract description 16
- 235000016646 Citrus taiwanica Nutrition 0.000 claims abstract description 16
- 244000184734 Pyrus japonica Species 0.000 claims abstract description 16
- 241000207929 Scutellaria Species 0.000 claims abstract description 16
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 12
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 12
- 239000010231 banlangen Substances 0.000 claims abstract description 12
- 210000000232 gallbladder Anatomy 0.000 claims abstract description 12
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 3
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 3
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 5
- 244000183685 Citrus aurantium Species 0.000 claims abstract 3
- 241000202807 Glycyrrhiza Species 0.000 claims description 16
- 241001127637 Plantago Species 0.000 claims description 12
- 241000132012 Atractylodes Species 0.000 claims description 9
- 244000170916 Paeonia officinalis Species 0.000 claims description 7
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 7
- 244000133098 Echinacea angustifolia Species 0.000 claims description 5
- 235000014134 echinacea Nutrition 0.000 claims description 5
- 240000001008 Dimocarpus longan Species 0.000 claims 3
- 235000000235 Euphoria longan Nutrition 0.000 claims 3
- BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 claims 2
- 208000002193 Pain Diseases 0.000 abstract description 32
- 210000004185 liver Anatomy 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 15
- 239000002994 raw material Substances 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 238000010926 purge Methods 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000007791 dehumidification Methods 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 241000219061 Rheum Species 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 240000003791 Citrus myrtifolia Species 0.000 description 13
- 241001071795 Gentiana Species 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- 206010007247 Carbuncle Diseases 0.000 description 10
- 239000002775 capsule Substances 0.000 description 8
- 235000008504 concentrate Nutrition 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 239000002552 dosage form Substances 0.000 description 8
- 239000006187 pill Substances 0.000 description 8
- 206010037844 rash Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010068319 Oropharyngeal pain Diseases 0.000 description 7
- 201000007100 Pharyngitis Diseases 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 208000010201 Exanthema Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 244000292697 Polygonum aviculare Species 0.000 description 6
- 235000006386 Polygonum aviculare Nutrition 0.000 description 6
- 241000208422 Rhododendron Species 0.000 description 6
- 201000005884 exanthem Diseases 0.000 description 6
- 235000012907 honey Nutrition 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 208000004296 neuralgia Diseases 0.000 description 5
- 210000003800 pharynx Anatomy 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 206010013789 Dry throat Diseases 0.000 description 3
- 206010016825 Flushing Diseases 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 2
- 201000006082 Chickenpox Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 201000005807 Japanese encephalitis Diseases 0.000 description 2
- 241000710842 Japanese encephalitis virus Species 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241001426056 Eleusine coracana subsp. coracana Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000004454 Hyperalgesia Diseases 0.000 description 1
- 208000035154 Hyperesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000007199 Panicum miliaceum Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010034829 Pharyngeal oedema Diseases 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
- 208000037048 Prodromal Symptoms Diseases 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004889 cervical nerve Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000001937 intercostal nerve Anatomy 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 208000018555 lymphatic system disease Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000030247 mild fever Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000002276 neurotropic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940018492 plantago seed Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000003594 spinal ganglia Anatomy 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗带状疱疹的中药组合物,其中,各原料药按照重量分数比配置如下:鸦葱10-30份,地胆草5-15份,黄芩5-15份,赤芍5-15份,甘草5-15份,木通10-20份,车前子10-20份,大黄10-20份,苍术5-15份,枳壳5-15份,龙胆草5-15份,板蓝根10-20份,虎杖10-20份,蝉蜕5-15份。本发明所述的中药组合物为验方,泻肝胆实火,健脾除湿,疏肝理气,活血止痛,且药源广泛、无毒副作用的,能够有效治疗带状疱疹,治疗效果显著,成功率高,有效率达89.2%。
Description
技术领域
本发明涉及含有来源于植物原料的医用配制品,特别涉及一种治疗带状疱疹的中药组合物及其制备方法。
背景技术
带状疱疹好发于成人,春秋季节多见。发病率随年龄增大而呈显著上升。无论有疹或无疹类型,疼痛难眠是其主要特点,病变部位的皮肤,有灼热、刺痛感,数天后,出疹型患者见到密集的小水泡,周围皮肤发红、病变部位如火烧灼一般疼痛。病情较严重的可见淋巴结肿大、发热等全身症状。局部簇集水泡沿一侧周围神经作群集带状分布,伴有明显神经痛。人是带状疱疹病毒的唯一宿主,病毒经呼吸道黏膜进入血液形成感染,并可长期潜伏体内。当机体受到某种刺激(如创伤、疲劳、恶性肿瘤或病后虚弱等)导致机体抵抗力下降时,潜伏病毒被激活,沿感觉神经轴索下行到达该神经所支配区域的皮肤内复制产生水疱,同时受累神经发生炎症、坏死,产生神经痛。发疹前可有轻度乏力、低热、纳差等全身症状,患处皮肤自觉灼热感或者神经痛,触之有明显的痛觉过敏,持续1~3天,亦可无前驱症状即发疹。好发部位依次为肋间神经、颈神经、三叉神经和腰骶神经支配区域。患处常首先出现潮红斑,很快出现粟粒至黄豆大小的丘疹,簇状分布而不融合,继之迅速变为水疱,疱壁紧张发亮,疱液澄清,外周绕红晕,各簇水疱群间皮肤正常。皮损沿周围神经呈带状排列,多发生在身体的一侧,一般不超过正中线。带状疱疹病毒即水痘-带状疱疹病毒(varicella-zoster virus,VZV),该病毒原发感染水痘(儿童),复发感染带状疱疹(成人)。由于病毒具有亲神经性,感染后可长期潜伏于脊髓神经后根神经节的神经元内,当抵抗力低下或劳累、感染、感冒发烧,生气上火等,病毒可再次生长繁殖,并沿神经纤维移至皮肤,使受侵犯的神经和皮肤产生激烈的炎症。皮疹一般有单侧性和按神经节段分布的特点,有集簇性的疱疹组成,并伴有疼痛;年龄愈大,神 经痛愈重。此病现代医学称为带状疱疹,民间称为蛇胆疮,缠腰龙,飞蛇等称。
带状疱疹属于寒湿邪气被真阳驱赶外泛于皮肤的表现,仅有神经疼痛而无疱疹的(即无疹型),属于真阳无力将寒湿驱赶至皮外的表现,出现红疹或水泡的,属于真阳将寒湿邪气驱赶于皮表的表现。一般患者于疱疹发生前数天会有轻度发热、疲乏等症状,这就是真阳发动的表现。带状疱疹热证患者皮肤潮红,疱壁紧张,疼痛剧烈,伴有口苦咽干,烦躁易怒,小便黄,大便干,舌质红,苔黄,脉弦滑。治宜清泻肝胆实火。湿症患者皮肤淡红,疱壁松弛,疼痛较轻,纳差或腹胀,大便溏,舌质淡,苔白厚或白腻,脉沉缓。治宜健脾除湿。若带状疱疹消退后局部疼痛不止者,属气滞血瘀,治宜疏肝理气,活血止痛。外用中药可根据病情选用清热解毒消肿或祛湿收干之药水煎外敷。不论何种方法,带状疱疹的治疗应掌握时机,越早治疗效果越好。经常有些中老年患者,在带状疱疹完全清退后仍疼痛不止,局部皮肤完好无损却不敢触及。其疼痛的体质是受累神经节的炎症甚至坏死,疼痛的程度轻重及时间长短与皮疹不一定保持一致。尤其是老年人,随着年龄的增长机体的各种机能都在减退,受损的神经组织修复也较困难,故很容易发生后遗神经痛。特别是平素体质较差,或治疗不及时者,此种疼痛可持续数月甚至更久。
带状疱疹的通常医疗方法常不能断根,即使疱疹症状缓解,但仍疼痛不止。中药是中华民族的文化瑰宝之一,其对于治疗带状疱疹有显著疗效,其在清泻肝胆实火,健脾除湿,疏肝理气,活血止痛方面效果显著,且药源多来自植物提取物,无毒副作用。中药在治疗带状疱疹上有其独特优势。
发明内容
本发明所要解决的技术问题在于,提供一种清泻肝胆实火,健脾除湿,疏肝理气,活血止痛方面效果显著,且药源广泛、无毒副作用的,能够有效治疗带状疱疹的,其效果显著的一种治疗带状疱疹的中药组合物及其制备方法。
为解决上述技术问题,本发明提供了一种治疗带状疱疹的中药组合物,其中,各原料药按照重量分数比配置如下:鸦葱10-30份,地胆草5-15份,黄 芩5-15份,赤芍5-15份,甘草5-15份,木通10-20份,车前子10-20份,大黄10-20份,苍术5-15份,枳壳5-15份,龙胆草5-15份,板蓝根10-20份,虎杖10-20份,蝉蜕5-15份。
或者,各原料药按照重量分数比配置如下:鸦葱20-30份,地胆草10-15份,黄芩10-15份,赤芍10-15份,甘草10-15份,木通15-20份,车前子15-20份,大黄15-20份,苍术10-15份,枳壳10-15份,龙胆草10-15份,板蓝根15-20份,虎杖15-20份,蝉蜕10-15份。
或者,各原料药按照重量分数比配置如下:鸦葱10-20份,地胆草5-10份,黄芩5-10份,赤芍5-10份,甘草5-10份,木通10-15份,车前子10-15份,大黄10-15份,苍术5-10份,枳壳5-10份,龙胆草5-10份,板蓝根10-15份,虎杖10-15份,蝉蜕5-10份。
或者,各原料药按照重量分数比配置如下:鸦葱15-25份,地胆草8-12份,黄芩8-12份,赤芍8-12份,甘草8-12份,木通12-16份,车前子12-16份,大黄12-16份,苍术8-12份,枳壳8-12份,龙胆草8-12份,板蓝根12-16份,虎杖12-16份,蝉蜕8-12份。
本发明中药组合物在使用煎汤剂服用时,每日1剂,分两次服,每7天为一疗程。
本发明中药组合物的剂型为:蜜炼丸剂、水合丸剂、胶囊、口服液、片剂、滴丸剂或糖浆剂。
为更好的实现本发明目的,本发明还提供了一种治疗带状疱疹的中药组合物的制备方法,其中,当中药组合物的剂型为蜜炼丸剂,其制备方法为:
将所述各原料药加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,与蜂蜜混在一起搓成细条,制成蜜炼丸并腊封包装。
当中药组合物的剂型为胶囊剂,其制备方法为:
将所述原料药加重量10倍量的乙醇,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/mL,抽 滤后,滤液的相对密度为20℃时1.08;所述滤液流经体积为10L的吸附树脂柱,之后用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除乙醇溶剂,得到组份药粉,装入胶囊制为胶囊剂。
当中药组合物的剂型为片剂,其制备方法为:
将所述各原料药切碎加入到多功能提取罐内,加入重量份数比为3000份的水浸泡30~40分钟,煎煮1.5小时后,取出第一次煎煮液备用;药渣加入重量份数比为3000份的水煎煮1小时后,取出第二次煎煮液,将前述两次煎煮液合并过滤,滤液减压浓缩至重量份数比为1000份的溶液,静置沉淀24~36小时,吸取上清液,加热至40~50℃后加入淀粉,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,制片、干燥、成型、分装。
本发明中药组合物,泻肝胆实火,健脾除湿,疏肝理气,活血止痛,且药源广泛、无毒副作用的,能够有效治疗带状疱疹及其疼痛症状,治疗效果显著,成功率高,有效率达89.2%。
具体实施方式
本发明公开了一种治疗带状疱疹的中药组合物,其中,各原料药按照重量分数比配置如下:鸦葱10-30份,地胆草5-15份,黄芩5-15份,赤芍5-15份,甘草5-15份,木通10-20份,车前子10-20份,大黄10-20份,苍术5-15份,枳壳5-15份,龙胆草5-15份,板蓝根10-20份,虎杖10-20份,蝉蜕5-15份。
或者,各原料药按照重量分数比配置如下:鸦葱20-30份,地胆草10-15份,黄芩10-15份,赤芍10-15份,甘草10-15份,木通15-20份,车前子15-20份,大黄15-20份,苍术10-15份,枳壳10-15份,龙胆草10-15份,板蓝根15-20份,虎杖15-20份,蝉蜕10-15份。
或者,各原料药按照重量分数比配置如下:鸦葱10-20份,地胆草5-10份,黄芩5-10份,赤芍5-10份,甘草5-10份,木通10-15份,车前子10-15份,大黄10-15份,苍术5-10份,枳壳5-10份,龙胆草5-10份,板蓝根10-15份,虎杖10-15份,蝉蜕5-10份。
或者,各原料药按照重量分数比配置如下:鸦葱15-25份,地胆草8-12 份,黄芩8-12份,赤芍8-12份,甘草8-12份,木通12-16份,车前子12-16份,大黄12-16份,苍术8-12份,枳壳8-12份,龙胆草8-12份,板蓝根12-16份,虎杖12-16份,蝉蜕8-12份。
本发明中药组合物在使用时煎汤剂服用时,每日1剂,分两次服,每7天为一疗程。
本发明中药组合物的剂型为:蜜炼丸剂、水合丸剂、胶囊、口服液、片剂、滴丸剂或糖浆剂。
本发明中各成分:
鸦葱,苦,寒。用于清热解毒,活血消肿。外用治疔疮,痈疽,毒蛇咬伤,蚊虫叮咬,乳腺炎等。消肿解毒。主五痨七伤;疔疮痈肿。《江苏药材志》:消肿解毒。治五痨七伤,疔疮痈肿。《宁夏中草药手册》:微苦,寒。
地胆草,性能:性寒,味苦辛;清热解毒,凉血消肿,止咳利尿。用于清热解毒,利尿消肿。用于感冒,急性扁桃体炎,咽喉炎,眼结膜炎,流行性乙型脑炎,百日咳,急性黄疸型肝炎,肝硬化腹水,急、慢性肾炎,疖肿,湿疹。
黄芩,可治瘟病发热,肺热咳嗽、湿热黄疸,泻痢、胎动不安等症,并有抗菌、解热、降压,泻火清瘟等作用。
赤芍,苦,微寒。归肝经。清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。《本经》:“味苦,平。”《吴普本草》:“桐君:甘,无毒。歧伯:咸。李氏:小寒。雷公:酸。”《别录》:“酸,平微寒,有小毒。”《本草衍义》:“味涩苦。”入肝、脾经。
甘草,性平,味甘,归十二经。有解毒、祛痰、止痛、解痉以至抗癌等药理作用。在中医上,调和百药.补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。《本草汇言》:甘草,和中益气,补虚解毒之药也。健脾胃,固中气之虚羸,协阴阳,和不调之营卫。故治劳损内伤,脾气虚弱,元阳不足,肺气衰虚,其甘温平补,效与参、芪 并也。又如咽喉肿痛,佐枳实、鼠粘,可以清肺开咽;痰涎咳嗽,共苏子、二陈,可以消痰顺气。.《本草新编》:甘草,味甘,气平,性温,可升可降,阳中阳也。无毒。入太阴、少阴、厥阴之经。
木通,性味:苦、微寒。归经:入心经、小肠经、膀胱经。功能:清心火,利小便,通经下乳。主治:用于胸中烦热,喉痹咽痛,尿赤,五淋,水肿,周身挛痛。《别录》:疗脾疸常欲眠,心烦哕,出音声,疗耳聋,散痈肿诸结不消,及金疮、恶疮、鼠痿、踒折、齆鼻息肉,堕胎,去三虫。
车前子,甘,寒。《本经》:主气癃、止痛,利水道小便,除湿痹。《山东中药》:敷湿疮、泡疮、小儿头疮。《药性沦》:能去风毒,肝中风热,毒风冲眼目,赤痛障翳,脑痛泪出,去心胸烦热。
大黄,性味:苦,寒。归经:胃经;大肠经;肝经;脾经。功效:攻积滞;清湿热;泻火;凉血;祛瘀;解毒。主治:实热便秘;热结胸痞;湿热泻痢;黄疸;淋病;水肿腹满;小便不利;目赤;咽喉肿痛;口舌生疮;胃热呕吐;吐血;咯血;衄血;便血;尿血;蓄血;经闭;产后瘀滞腹痛;症瘕积聚;跌打损伤;热毒痈疡;丹毒;烫伤。泻热通肠,凉血解毒,逐瘀通经。用于实热便秘,积滞腹痛,泻痢不爽,湿热黄疸,血热吐衄,目赤,咽肿,肠痈腹痛,痈肿疔疮,瘀血经闭,跌打损伤,外治水火烫伤;上消化道出血。酒大黄善清上焦血分热毒。用于目赤咽肿,齿龈肿痛。熟大黄泻下力缓,泻火解毒。用于火毒疮疡。大黄炭凉血化瘀止血。用于血热有瘀出血者。
苍术,辛、苦,温。归脾、胃、肝经。燥湿健脾,祛风散寒,明目。用于脘腹胀满,泄泻水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲。
枳壳,性味苦;酸;性微寒归经:肺;脾;肝;胃;大肠经功能主治:胸隔痞满;胁肋胀痛;食积不化;脘腹胀满;下痢后重;脱肛;子宫脱垂。治风疹痒不止。
龙胆草,具有清热、泻肝、定惊之功效。《本草纲目》记载:“性味苦,涩,大寒,无毒。主治骨间寒热、惊病邪气,继绝伤,定五脏,杀虫毒。”.《日华子本草》:治客忤,疳府气,热病狂语,疮疥,明目,止烦。
板蓝根,具有抗菌抗病毒作用和解毒作用。《本草述》:苦,寒,无毒。清热,解毒,凉血,利咽。主治:温毒发斑;高热头痛;大头瘟疫;舌绛紫暗,烂喉丹痧;丹毒;痄腮;喉痹;疮肿、痈肿;水痘;麻 疹;肝炎;流行性感冒,流脑,乙脑,肺炎,神昏吐衄,咽肿,火眼,疮疹;可防治流行性乙型脑炎、急慢性肝炎、流行性腮腺炎、骨髓炎。
虎杖,微苦,微寒。归肝、胆、肺经。功能与主治:清热解毒,利胆退黄,祛风利湿,散瘀定痛,止咳化痰。用于关节痹痛,湿热黄疸,经闭,癓瘕,咳嗽痰多,水火烫伤,跌扑损伤,痈肿疮毒。
蝉蜕:甘,寒。归肺、肝经。功能:散风除热,利咽,透疹,退翳,解痉。用于风热感冒,咽痛,音哑,麻疹不透,风疹瘙痒,目赤翳障,惊风抽搐,破伤风。
制备方法中:
本发明的中药组合物的剂型为蜜炼丸剂,其制备方法为:
将所述各原料药加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,与蜂蜜混在一起搓成细条,制成蜜炼丸并腊封包装。
本发明的中药组合物的剂型为胶囊剂,其制备方法为:
将所述原料药加重量10倍量的乙醇,加热回流提取3次,每次2小时,将3次提取液合并,减压回收乙醇,并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度为20℃时1.08;所述滤液流经体积为10L的吸附树脂柱,之后用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除乙醇溶剂,得到组份药粉,装入胶囊制为胶囊剂。
本发明的中药组合物的剂型为片剂,其制备方法为:
将所述各原料药切碎加入到多功能提取罐内,加入重量份数比为3000份的水浸泡30~40分钟,煎煮1.5小时后,取出第一次煎煮液备用;药渣加入重量份数比为3000份的水煎煮1小时后,取出第二次煎煮液,将前述两次煎煮液合并过滤,滤液减压浓缩至重量份数比为1000份的溶液,静置沉淀24~36小时,吸取上清液,加热至40~50℃后加入淀粉,加热浓缩至糊状,放入烘箱,控制在80℃,烘干后冷却,制片、干燥、成型、分装。
具体举例如下
实施例1:王先生,男,24岁。患者皮肤淡红起水泡,泡壁松弛,破后糜烂渗出,疼痛较轻,口渴而不欲饮,纳差或食后腹胀,大便溏,舌质淡白体胖,脉沉缓而滑。经诊断为带状疱疹患者,使用如下配方:鸦葱30g,地胆草15g,黄芩15g,赤芍15g,甘草15g,木通20g,车前子20g,大黄20g,苍术15g,枳壳15g,龙胆草15g,板蓝根20g,虎杖20g,蝉蜕15g。使用时煎汤剂服用,每日1剂,分两次服,每7天为一疗程。服用2个疗程后,症状减退,继续服用1疗程,带状疱疹消失,巩固疗效继续服用1疗程后痊愈,半年后追访,未复发。
实施例2:张女士,39岁,患者皮肤潮红,有水泡,疱壁紧张,灼热刺痛形成红粟,口苦咽干,口渴,烦躁易怒,小便短赤,大便干结,舌质红,苔薄黄,脉沉缓而滑。经诊断为带状疱疹患者,使用如下配方:鸦葱10g,地胆草5g,黄芩5g,赤芍5g,甘草5g,木通10g,车前子10g,大黄10g,苍术5g,枳壳5g,龙胆草5g,板蓝根10g,虎杖10g,蝉蜕5g。使用时煎汤剂服用,每日1剂,分两次服,每7天为一疗程。服用3个疗程后,症状减退,继续服用1疗程,带状疱疹消失,巩固疗效继续服用1疗程后痊愈,三个月后追访,未复发。
实施例3:李先生,53岁,患者皮肤潮红,疱壁紧张,有水泡,疼痛剧烈,伴有口苦咽干,烦躁易怒,小便黄,大便干,舌质红,苔黄,脉弦滑。经诊断为带状疱疹患者,使用如下配方:鸦葱15g,地胆草8g,黄芩8g,赤芍8g,甘草8g,木通12g,车前子12g,大黄12g,苍术8g,枳壳8g,龙胆草8g,板蓝根12g,虎杖12g,蝉蜕8g。使用时煎汤剂服用,每日1剂,分两次服,每7天为一疗程。服用2个疗程后,症状减退,继续服用2疗程,带状疱疹消失,巩固疗效继续服用1疗程后痊愈,半年后追访,未复发。
实施例4:张阿姨,47岁,皮肤淡红,疱壁不明显,侧胸壁局部疼痛较重,纳差或腹胀,大便溏,舌质淡,苔白厚,经诊断为带状疱疹患者,使用如下配方:鸦葱25g,地胆草12g,黄芩12g,赤芍12g,甘草12g,木通16g,车前子16g,大黄16g,苍术12g,枳壳12g,龙胆草12g,板蓝根16g,虎杖16g,蝉蜕12g。使用时煎汤剂服用,每日1剂,分两次服, 每7天为一疗程。服用2个疗程后,症状减退,继续服用1疗程,带状疱疹消失,巩固疗效继续服用1疗程后痊愈,半年后追访,未复发。
使用本发明配方,2011年上半年收治120例中,有效率达89.2%。本发明清的中药组合物,泻肝胆实火,健脾除湿,疏肝理气,活血止痛,且药源广泛、无毒副作用的,能够有效治疗带状疱疹,治疗效果显著,成功率高。
Claims (4)
1.一种治疗带状疱疹的中药组合物,其特征在于,各原料药按照重量分数比配置如下:鸦葱10-30份,地胆草5-15份,黄芩5-15份,赤芍5-15份,甘草5-15份,木通10-20份,车前子10-20份,大黄10-20份,苍术5-15份,枳壳5-15份,龙胆草5-15份,板蓝根10-20份,虎杖10-20份,蝉蜕5-15份。
2.根据权利要求1所述治疗带状疱疹的中药组合物,其特征在于,各原料药按照重量分数比配置如下:鸦葱20-30份,地胆草10-15份,黄芩10-15份,赤芍10-15份,甘草10-15份,木通15-20份,车前子15-20份,大黄15-20份,苍术10-15份,枳壳10-15份,龙胆草10-15份,板蓝根15-20份,虎杖15-20份,蝉蜕10-15份。
3.根据权利要求1所述治疗带状疱疹的中药组合物,其特征在于,各原料药按照重量分数比配置如下:鸦葱10-20份,地胆草5-10份,黄芩5-10份,赤芍5-10份,甘草5-10份,木通10-15份,车前子10-15份,大黄10-15份,苍术5-10份,枳壳5-10份,龙胆草5-10份,板蓝根10-15份,虎杖10-15份,蝉蜕5-10份。
4.根据权利要求1所述治疗带状疱疹的中药组合物,其特征在于,各原料药按照重量分数比配置如下:鸦葱15-25份,地胆草8-12份,黄芩8-12份,赤芍8-12份,甘草8-12份,木通12-16份,车前子12-16份,大黄12-16份,苍术8-12份,枳壳8-12份,龙胆草8-12份,板蓝根12-16份,虎杖12-16份,蝉蜕8-12份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210023151.XA CN102552492B (zh) | 2012-01-12 | 2012-01-12 | 一种治疗带状疱疹的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210023151.XA CN102552492B (zh) | 2012-01-12 | 2012-01-12 | 一种治疗带状疱疹的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552492A CN102552492A (zh) | 2012-07-11 |
CN102552492B true CN102552492B (zh) | 2014-04-30 |
Family
ID=46399947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210023151.XA Expired - Fee Related CN102552492B (zh) | 2012-01-12 | 2012-01-12 | 一种治疗带状疱疹的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552492B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988692B (zh) * | 2012-11-13 | 2014-12-17 | 黄文珍 | 治疗带状疱疹的中药组合物及其制备方法 |
CN103656361B (zh) * | 2013-12-10 | 2015-06-03 | 张朝兰 | 一种治疗带状疱疹的药物及其制备方法 |
CN106138251A (zh) * | 2016-08-25 | 2016-11-23 | 颜喜贤 | 一种治疗带状疱疹的中药组合物 |
CN108126084A (zh) * | 2018-01-11 | 2018-06-08 | 孙鲁娜 | 一种治疗扁平疣的中药组合物及其在皮肤科的应用 |
CN111904991A (zh) * | 2020-09-24 | 2020-11-10 | 郑州铭泽生物科技有限公司 | 一种治疗带状疱疹的中药组合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411733A (en) * | 1992-04-27 | 1995-05-02 | Hozumi; Toyoharu | Antiviral agent containing crude drug |
CN100571731C (zh) * | 2007-04-16 | 2009-12-23 | 北京艺信堂医药研究所 | 一种治疗带状疱疹的中药汤剂 |
CN101129881A (zh) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | 一种治疗乳房带状疱疹的中药组合物 |
CN101332253A (zh) * | 2008-04-02 | 2008-12-31 | 曹青山 | 一种治疗带状疱疹的中药制剂及其制法 |
CN101596252B (zh) * | 2009-07-14 | 2011-08-10 | 王婷 | 一种治疗带状疱疹的组合物及其制备方法 |
CN101703732B (zh) * | 2009-09-29 | 2011-06-08 | 李家娣 | 一种治疗带状疱疹的中药膏及其制备方法 |
-
2012
- 2012-01-12 CN CN201210023151.XA patent/CN102552492B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102552492A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552492B (zh) | 一种治疗带状疱疹的中药组合物及其制备方法 | |
CN104667047A (zh) | 一种治疗糖尿病足的中药液 | |
CN102512564A (zh) | 治疗痛经的中药 | |
CN102488758B (zh) | 治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN104288328A (zh) | 一种治疗带状疱疹的中药组合物及其制备方法 | |
CN103007063A (zh) | 一种治疗面瘫的药物组合物及其制备方法 | |
CN100571764C (zh) | 一种治疗带状疱疹的中药汤剂 | |
CN104208243B (zh) | 治疗带状疱疹的中药药浴及制备方法 | |
CN103705614B (zh) | 一种治疗带状疱疹的中药 | |
CN102366510A (zh) | 一种治疗皮质醇增多症的中药 | |
CN102940770A (zh) | 一种急性炎症性脱髓鞘性多发性神经病的中药 | |
CN101940720A (zh) | 治疗消化性溃疡(瘀血阻络)的中草药 | |
CN105343298A (zh) | 一种治疗慢性便秘的肚脐贴及其制备方法 | |
CN104524149A (zh) | 一种防治急性肾炎的药物组合物及其应用 | |
CN105327157A (zh) | 一种治疗脑血管堵塞的中药及其制备方法 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN105412601A (zh) | 用于抗化疗副反应的口服液 | |
CN103505713B (zh) | 一种治疗营卫不和证型肌痹病的中药组合物 | |
CN104825846A (zh) | 一种治疗面神经炎的中药组合物 | |
CN104288396A (zh) | 一种治疗老年痴呆症的中药汤剂 | |
CN104116842A (zh) | 一种治疗带状疱疹的外用中药组合物及其制备方法 | |
CN103656220A (zh) | 一种治疗脾肾阳虚型慢性肠炎的中药 | |
CN101249194A (zh) | 一种治疗胃痛的中药制剂 | |
CN105748708A (zh) | 一种治疗慢性荨麻疹的中药 | |
CN104547903A (zh) | 一种治疗产后综合症的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 Termination date: 20150112 |
|
EXPY | Termination of patent right or utility model |